[Histomorphological investigations of endometrial carcinoma during progestional treatment with chlormadione acetate (author's transl)].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002715:Chlormadinone Acetate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003593:Cytoplasm / Q000187:drug effects; D004487:Edema; D004848:Epithelium / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006003:Glycogen / Q000096:biosynthesis; D006801:Humans; D008679:Metaplasia; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects; D009093:Mucus / Q000378:metabolism; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology
D002715:Chlormadinone Acetate; D006003:Glycogen
Histomorphologische Untersuchungen an Endometriumkarzinomen unter Gestagen-Therapie (Chlormadinonazetat.